Amedisys (NASDAQ: AMED) reported Q1 EPS of $1.00, $0.11 better than the analyst estimate of $0.89. Revenue for the quarter came in at $556.4 million versus the consensus estimate of $558.81 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.